Cannabis companies are not thinking enough about potential threats to their data and the information of their clients, a cybersecurity expert claims.

In a talk during the 2020 edition of the Vancouver Lift & Co. (TSXV:LIFT,OTCQB:LFCOF) Cannabis Expo, Hanna Shanes, chief compliance officer at 365 Cannabis, told the audience that, as data becomes a more urgent item in the cannabis industry, companies should spend more time and resources on protecting it.


Following her panel, Shanes told the Investing News Network (INN) that currently she gets the sense that data protection measures and standards are a low priority for the cannabis companies she’s talked to.

“I think the bigger organizations are thinking of it, but I think that often the impetus for them taking action is either a consumer inquiry, in which case it’s nearly too late, or it’s an audit for some of these publicly traded companies (that) is the first moment that they realize they have to get real about security and privacy,” she explained.

Shanes’ firm, Colorado-based 365 Cannabis, offers customers software solutions designed for the marijuana industry. In her view, cannabis companies will ultimately become more interested in the protection of data through a consumer movement rather than via any potential breaches.

Throughout the latest Lift Expo, experts in the marijuana space echoed the sentiment that data is becoming a cornerstone item for all cannabis operations, and stressed the need for corporations to collect information as part of every interaction with users and consumers.

According to Shanes, all cannabis companies should employ a data security officer, which is a role she described as not exclusively designed for an executive. This person would oversee policies and procedures or data protection.

During the panel, Shanes explained that the person in this role should be able to answer queries from consumers and other interested parties at any given time. In the event of an actual attack, they would lead the charge in the response.

When it comes to how investors can evaluate the measures a cannabis company uses to guarantee its privacy against potential threats, Shanes told INN to look out for firms taking ownership of this responsibility, rather than passing the duty to someone else.

“Everybody’s looking for the easy button,” said Shanes. “So they just want to outsource responsibility to someone else.”

As part of her panel, Shanes explained the various ways consumers and their information are supposed to be protected. The expert broke down how different policies, such as Canada’s Privacy Act and the Personal Information Protection and Electronic Documents Act, offer protections to the data collected by private corporations.

In Canada, all the licensed producers must issue a monthly report to Health Canada with information from their customers and patients. However, Shanes confirmed this information is usually aggregated so there is little to no worry of potential breaches exposing consumers’ personal details.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”) Is pleased to announce its partially owned subsidiary NeonMind (CSE: NEON) (“NeonMind”) has common shares now trading on the Frankfurt Stock Exchange (the “FSE”) under the symbol “6UF”. As a result, NeonMind’s common shares are now cross-listed on the Canadian Securities Exchange and the FSE. Shares of Better Plant are available on the FSE under the symbol “YG3”.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/72301_betterplanta.jpg

Keep reading... Show less

Chemesis International Inc. (the “Company”) (CSE: CSI) (OTC: CADMF) (FRA: CWAA) is pleased to announce that all matters submitted to the shareholders of the Company at the Annual General and Special Meeting of the Company’s shareholders held on December 31, 2020 were approved.
In addition, the Company has granted, pursuant to its Equity Incentive Plan, options to purchase 1,500,000 shares of the Company exercisable for a period of 5 years at USD$0.70 per share to the directors, officers and consultants of the Company. The Company has also granted, pursuant to its Equity Incentive Plan, restricted share rights to acquire 1,500,000 shares of the Company to the directors, officers and consultants of the Company. One-half of such restricted share rights shall vest in three months from the grant date and the remaining one-half shall vest in six months from the grant date.
On Behalf of The Board of Directors
Josh Rosenberg
President
Investor Relations:
ir@chemesis.com
1 (604) 398-3378
The CSE has not reviewed, approved or disapproved the content of this press release

Source

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf”, “OILS”, or the “Company”), the world’s most innovative cannabis extractor, announced today that the Canadian Intellectual Property Office has granted the Company a patent for the acetylation of cannabinoids. More specifically, the patent covers a process for acetylating cannabidiol (“CBD”), and subsequent refinement of CBD-O-Acetate using a proprietary extraction and distillation technique.

Keep reading... Show less

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) The Company announces that it has recently negotiated an extension to its option to purchase another 21% of Arcology for another year by an investment of $1,000,000. If the company exercises that option, it would then own 51

The Company is clarifying that in its press release of January 15th regarding the signing of a definitive agreement to acquire bit mining infrastructure, that the first phase will deliver 9,450 terahash per second, not 9,450 petahash as stated.

Keep reading... Show less

Appointment of Philip Young as CEO and director adds a seasoned executive with a track record of new device and therapeutics development, FDA/regulatory approvals, capital markets, M&A and operational success

 Lobe Sciences Ltd (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the appointment of Mr. Philip J. Young as Chief Executive Officer, Corporate Secretary and a director of the Company, effective January 15, 2021. Mr. Young replaces Thomas Baird, who resigned as CEO as of the same date.

Keep reading... Show less